MedPath

Pranactin-Citric

Approved
Approval ID

571577b1-2160-4c2f-b953-062c15373fcb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 24, 2009

Manufacturers
FDA

Otsuka America Pharmaceutical

DUNS: 008314390

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

UREA C-13

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59148-023
Application NumberNDA020586
Product Classification
M
Marketing Category
C73594
G
Generic Name
UREA C-13
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 18, 2009
FDA Product Classification

INGREDIENTS (4)

UREA C-13Active
Quantity: 75 mg in 3000 mg
Code: W6KX9E6D8X
Classification: ACTIM
ANHYDROUS CITRIC ACIDInactive
Quantity: 2000 mg in 3000 mg
Code: XF417D3PSL
Classification: IACT
MANNITOLInactive
Quantity: 775 mg in 3000 mg
Code: 3OWL53L36A
Classification: IACT
ASPARTAMEInactive
Quantity: 150 mg in 3000 mg
Code: Z0H242BBR1
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pranactin-Citric - FDA Drug Approval Details